← Open Payments lookup

DARA GUTHRIE: Open Payments

NPI 1417683103 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$594 in 27 payments from 10 companies in 2025. Trend: 2023 $317 · 2024 $462 · 2025 $594

Food & beverage: $594
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.8$156
Bayer Healthcare Pharmaceuticals Inc.6$130
AstraZeneca Pharmaceuticals LP3$62
Novartis Pharmaceuticals Corporation2$62
Vifor Pharma, Inc.2$54
Boehringer Ingelheim Pharmaceuticals, Inc.2$35
Amgen Inc.1$28
Otsuka America Pharmaceutical, Inc.1$27
Travere Therapeutics, Inc.1$22
OPKO Pharmaceuticals, LLC1$17

Products named: TARPEYO, Kerendia, FARXIGA, Veltassa, JARDIANCE, Fabhalta, TAVNEOS, JYNARQUE.

Industry payments across TX — which companies pay providers there.